GILD

Gilead Sciences

GILD 24/7 trading Spot + perpetual

Underlying stock: GILD

$147.78 -0.49% 24h Volume: $12,092.65

146.88 Low / High 24h 150.03

Exchange

Issuer

—

Pair

GILD/USDT

Price history (USD)

Markets

Exchange	Pair	Price	24h %	24h Volume
	GILD/USDT	$147.78	-0.49%	$12,092.65
	rGILD/USDT	$148.04	-0.68%	—

Trade 24/7, weekends included: no broker account and no waiting for the opening bell.

Tokenized stocks are open only to eligible verified users, and each exchange decides where it offers them. Bybit states that its TradFi products are "not available to residents of the European Economic Area".

Also trades on

Bitget $148.04

Gilead Sciences develops and sells medicines for HIV, viral hepatitis and certain cancers, and researches treatments for other infectious and inflammatory diseases. Its HIV prevention and treatment drugs represent a major part of its business, alongside oncology therapies developed through its Kite Pharma subsidiary. Founded in 1987, headquartered in California.

What are tokenized stocks?

What is a tokenized stock?

It depends on the exchange. Some list a token backed 1:1 by a real share held at a custodian; others list a perpetual futures contract, quoted and settled in USDT, that only tracks the price with no share behind it. Both follow the same share price.

Can I trade when the stock market is closed?

Yes. These markets trade 24/7 on Bybit, including weekends and US market holidays, while the stock exchange itself is closed.

Do I own the actual share?

Not in either case. On the spot markets you hold a token backed by a real share held at a custodian, which gives you no shareholder rights; on the perpetual futures markets there is no share at all — the contract is settled in USDT and only tracks the price.

Who can trade tokenized stocks?

Tokenized stocks are open only to eligible verified users, and each exchange decides where it offers them. Bitget states that its tokenized stocks are "not offered to US Persons". Bybit states that its TradFi products are "not available to residents of the European Economic Area".